Randomized Controlled Trial
ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation.
Crit. Care Med. 2007 Jun 1;35(6):1457-63.
Review
Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
Emerg Med Australas. 2004 Aug 1;16(4):324-35.
Multicenter Study
A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial.
Crit. Care Med. 2008 Jan 1;36(1):14-23.